Abstract:Epidermal growth factor-like domain-containing protein 7 (EGFL7) is upregulated in human epithelial tumors and so is a potential biomarker for malignancy. Indeed, previous studies have shown that high EGFL7 expression promotes infiltration and metastasis of gastric carcinoma. The epithelial-mesenchymal transition (EMT) initiates the metastatic cascade and endows cancer cells with invasive and migratory capacity; however, it is not known if EGFL7 promotes metastasis by triggering EMT. We found that EGFL7 was overexpressed in multiple human gastric cancer (GC) cell lines and that overexpression promoted cell invasion and migration as revealed by scratch wound and transwell migration assays. Conversely, shRNA-mediated EGFL7 knockdown reduced invasion and migration. Furthermore, EGFL7-overexpressing cells grew into larger tumors and were more likely to metastasize to the liver compared to underexpressing CG cells following subcutaneous injection in mice. EGFL7 overexpression protected GC cell lines against anoikis, providing a plausible mechanism for this enhanced metastatic capacity. In excised human gastric tumors, expression of EGFL7 was positively correlated with expression levels of the mesenchymal marker vimentin and the EMT-associated transcription repressor Snail, and negatively correlated with expression of the epithelial cell marker E-cadherin. In GC cell lines, EGFL7 knockdown reversed morphological signs of EMT and decreased both vimentin and Snail expression. In addition, EGFL7 overexpression promoted EGF receptor (EGFR) and protein kinase B (AKT) phospho-activation, effects markedly suppressed by the EGFR tyrosine kinase inhibitor AG1478. Moreover, AG1478 also reduced the elevated invasive and migratory capacity of GC cell lines overexpressing EGFL7. Collectively, these results strongly suggest that EGFL7 promotes metastasis by activating EMT through an EGFR-AKT-Snail signaling pathway. Disruption of EGFL7-EGFR-AKT-Snail signaling may a promising therapeutic strategy for gastric cancer.

Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer

Frizzled7 Promotes Epithelial-To-Mesenchymal Transition And Stemness Via Activating Canonical Wnt/Beta-Catenin Pathway In Gastric Cancer

Zic1 Suppresses Gastric Cancer Metastasis by Regulating Wnt/β‐catenin Signaling and Epithelial‐mesenchymal Transition

FZD7 is a novel prognostic marker and promotes tumor metastasis via WNT and EMT signaling pathways in esophageal squamous cell carcinoma

Knockdown of Frizzled-7 Inhibits Cell Growth and Metastasis and Promotes Chemosensitivity of Esophageal Squamous Cell Carcinoma Cells by Inhibiting Wnt Signaling.

Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4

Overexpressed Lncrna GATA6-AS1 Inhibits LNM and EMT Via FZD4 Through the Wnt/β-Catenin Signaling Pathway in GC.

FSTL1 promotes growth and metastasis in gastric cancer by activating AKT related pathway and predicts poor survival

Frizzled7 as an emerging target for cancer therapy

The Keratin 17/YAP/IL6 Axis Contributes to E-cadherin Loss and Aggressiveness of Diffuse Gastric Cancer

Frizzled-7 Is Required for Wnt Signaling in Gastric Tumors with and Without Apc Mutations

Upregulation of Family with Sequence Similarity 83 Member D Expression Enhances Cell Proliferation and Motility Via Activation of Wnt/β-catenin Signaling and Predicts Poor Prognosis in Gastric Cancer

Fbxw7 Regulates Tumor Apoptosis, Growth Arrest and the Epithelial-to-mesenchymal Transition in Part Through the RhoA Signaling Pathway in Gastric Cancer.

Upregulation of HOXB7 promotes the tumorigenesis and progression of gastric cancer and correlates with clinical characteristics

Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.

Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer

Stromal fibroblast activation protein alpha promotes gastric cancer progression via epithelial-mesenchymal transition through Wnt/ β-catenin pathway

<p>Upregulation of family with sequence similarity 83 member D expression enhances cell proliferation and motility via activation of Wnt/β-catenin signaling and predicts poor prognosis in gastric cancer</p>

Cancer-associated fibroblast-derived WNT5A promotes cell proliferation, metastasis, stemness and glycolysis in gastric cancer via regulating HK2

Interaction between the EPHB2 receptor and EFNB1 ligand drives gastric cancer invasion and metastasis via the Wnt/β-catenin/FAK pathway

Increased Expression of Long-Noncoding RNA ZFAS1 is Associated with Epithelial-Mesenchymal Transition of Gastric Cancer